亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

富馬酸喹硫平,供應富馬酸喹硫平

 
 
單價 面議對比
詢價 暫無
發(fā)貨 湖北武漢市付款后3天內
庫存 1000公斤起訂1公斤
品牌 湖北恒碩-郭振華13971038453
型號 111974-72-2
規(guī)格 99%
過期 長期有效
更新 2015-06-03 16:10
 

湖北恒碩生化有限公司

企業(yè)會員第14年
資料未認證
保證金未繳納
詳細說明

富馬酸喹硫平 

中文別名:11-[4-[2-(2-羥基乙氧基)乙基]-1-哌嗪基]二苯并[b,f][1,4]硫氮雜卓半富馬酸鹽 

英文名稱:quetiapine fumarate 

英文別名: 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate; Quetiapine hemifumarate; quetiapine fumarate main intermediates; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol (2E)-but-2-enedioate (salt)  

CAS:111974-72-2 

分 子 式:C25H29N3O6S 

分 子 量:499.5793 

性 狀:白色結晶性粉末。 

包 裝:5kg/桶;25kg/紙板桶。 

舉報收藏 0評論 0
更多>本企業(yè)其它產品
鹽酸克林霉素,供應鹽酸克林霉素,克林霉素 奧卡西平,供應奧卡西平,氧痛驚寧 拉莫三嗪,供應拉莫三嗪,那蒙特金 加巴噴丁,供應加巴噴丁 鹽酸左氧氟沙星,氧氟沙星 果糖二磷酸鈉,供應果糖二磷酸鈉 氯磺丙脲,特泌胰,對氯苯磺酰丙脲,供應氯磺丙脲 苯丙氨酯,供應苯丙氨酯,強筋松
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |